Afasevikumab

Afasevikumab (RG 7624; RO 5553110; NI-1401) is a fully human monoclonal IgG1κ antibody neutralizing both IL-17A and IL-17F. Afasevikumab has anti-inflammatory activities.

$ 2,546.80 2546.8 USD $ 2,546.80

2,546.80 €

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Internal Reference: cell25sk38568
Size: 10mg